EU Safety Gate (RAPEX) · Portugal · 2016-07-22 · Serious risk
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Reported risk: The cream contains methylisothiazolinone (MI) and methylchloroisothiazolinone (MCI). Dermal contact with MCI/MI-containing products can provoke allergic contact dermatitis to sensitised persons.According to the Cosmetic Products Regulation, MCI/MI is prohibited in leave-on cosmetic products and shall not be made available on the Union market as from 16 April 2016.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.